EVEREST CLINICAL RESEARCH
LIVE

Serial Number

85216413

Owner

EVEREST CLINICAL RESEARCH CORPORATION

Attorney

Camille M. Miller

First Use Date

Oct 21, 2003

Filing Date

Jan 12, 2011

Add to watchlist:

No watchlists yet
View on USPTO

EVEREST CLINICAL RESEARCH Trademark

Serial Number: 85216413 • Registration: 4098088

EVEREST CLINICAL RESEARCH is a trademark filed by EVEREST CLINICAL RESEARCH CORPORATION on January 12, 2011. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EVEREST CLINICAL RESEARCH CORPORATION (6 trademarks)

675 COCHRANE DRIVE EAST TOWER, 4TH FLOOR
Ontario L3R0B8 , CA

Entity Type: 03

Everest Clinical Research Services Inc. (3 trademarks)

Suite 408, East Tower
Markham, Ontario L3R0B8 , CA

Entity Type: 03

Trademark Details

Filing Date

January 12, 2011

Registration Date

February 14, 2012

First Use Anywhere

October 21, 2003

First Use in Commerce

October 21, 2003

Published for Opposition

November 29, 2011

Goods & Services

Biomedical, pharmaceutical, biotechnology and health-related research study services, namely, conducting clinical trials in the field of clinical trials of drugs, medical devices and other interventions to determine efficacy and safety, namely, particularly, providing the selection of trial subjects in accordance with research design criteria, trial management and site monitoring, monitoring trial participants for adverse reactions and preparation and presentation of reports of adverse reactions, administration of clinical trial data and safety monitoring boards, collection and management of study data, clinical data management services and medical coding, analysis of study data including selection and application of statistical tests to study data, providing biostatistics and statistical programming, dispensing drugs and managing drug inventories, monitoring design and conduct of trials for compliance with applicable regulations and policies and preparation and presentation of compliance reports, development and maintenance of Internet websites for reporting on studies, medical writing and graphic design of research study protocols, preparation of reports of research studies and abstracts of reports, preparation and presentation of reports to study sponsors and regulatory authorities

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 26, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 26, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 26, 2021 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 26, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 18, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 14, 2021 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 31, 2018 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2017 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 14, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 13, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 13, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 14, 2017 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2017 TCCA
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 14, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2011 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 26, 2011 PREV
ASSIGNED TO LIE
Oct 26, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 5, 2011 GNRN
NON-FINAL ACTION E-MAILED
Apr 5, 2011 GNRT
NON-FINAL ACTION WRITTEN
Apr 5, 2011 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2011 NWOS